TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
LipoTrue announced three cosmetic active ingredients—Glintarine, Red Aternaliss and Kalizyme—at in-cosmetics Asia 2026. The company describes them as biotechnology-based ingredients for skin radiance, aging-related care and epidermal renewal; independent performance data and detailed test methods were not included in the source report.
LipoTrue introduced three cosmetic active ingredients—Glintarine™, Red Aternaliss™ and Kalizyme™—at in-cosmetics Asia 2026, adding formulations aimed at skin radiance, aging-related care and epidermal renewal to its portfolio. The launches target cosmetic formulators, and the company’s descriptions of their effects are product claims rather than independently verified findings in the available report.
Glintarine is described by LipoTrue as a marine ferment inspired by the sea-surface microlayer, the boundary where ocean water meets the atmosphere and light. The company says the ingredient is designed to influence melanin dynamics during epidermal renewal and support pigment redistribution and clearance. Its stated functions combine depigmenting, exfoliating and antioxidant activity. The report says visible results may appear from the first week, but does not specify the study design, participants or measurements behind that timing.
Red Aternaliss combines Edelweiss stem cells and red algae extracts. LipoTrue positions it as a cellular-longevity active intended to address what it calls the nine Hallmarks of Aging, supporting genomic protection, regeneration, cellular resilience and epidermal integrity. The company says the ingredient is intended to help maintain skin function and renewal over time, with smoother, more radiant and younger-looking skin among the anticipated cosmetic outcomes.
Kalizyme is described as a biomimetic enzyme modeled on human KLK7, produced through LipoTrue’s Wild Plants as Biofactories technology. According to the company, it draws on the skin’s natural desquamation process to provide controlled exfoliation while maintaining comfort, alongside support for active regeneration. The three launches take distinct approaches—marine fermentation, plant and algae-based ingredients, and enzyme biomimicry—while sharing a focus on cosmetic formulation and visible skin appearance.
Three Routes to Skin Renewal
The announcement gives cosmetic formulators three ingredient concepts for different product needs: Glintarine for the appearance of uneven tone and radiance, Red Aternaliss for aging-related skin care, and Kalizyme for exfoliation and renewal. Their separate mechanisms may let brands develop targeted formulations or position products around complementary concerns, rather than relying on a single general-purpose active.
The launches also illustrate how suppliers are translating biological processes and natural-source materials into cosmetic ingredients. LipoTrue describes the products as combining marine biotechnology, plant-based technologies and biomimetic science. For consumers, however, the announcement is not evidence that finished products containing these actives will deliver the stated outcomes. Effects can depend on concentration, formulation, use and the evidence supporting each product claim.
The distinction matters because ingredient launches are early steps in a longer chain from supplier development to a marketed product. Formulators will need to assess compatibility, stability, safety and performance in their own formulations. The source report does not provide prices, availability schedules or detailed efficacy data, so the commercial and consumer impact cannot yet be assessed.
Products Worth Considering
Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor
Fitbit Sense 2 Smartwatch – Blue Mist / Pale Gold
Levoit Vital 100S-P Air Purifier with Washable Pre-Filter
As an affiliate, we earn on qualifying purchases.
Launch at in-cosmetics Asia
LipoTrue presented the ingredients at in-cosmetics Asia 2026, a trade event for the cosmetics and personal-care industry. The company said visitors could view Glintarine, Red Aternaliss and Kalizyme at its booth V50. The announcement is therefore directed primarily at formulators and industry professionals evaluating new ingredients, rather than a retail launch of finished skin-care products.
The three actives are presented as complementary additions to LipoTrue’s existing cosmetic ingredient portfolio. The report links each to a specific development approach: Glintarine draws on a marine ferment, Red Aternaliss combines Edelweiss stem cells with red algae extracts, and Kalizyme uses a biomimetic enzyme produced with the company’s Wild Plants as Biofactories technology. These descriptions and intended uses come from the company’s product information as reported by Cosmetics Business.
Evidence Behind Product Claims
The available report does not provide clinical or instrumental study results, sample sizes, ingredient concentrations, test protocols or comparison groups for the stated skin effects. In particular, it does not explain how the claim of visible Glintarine results from the first week was assessed. That claim should be understood as a reported product statement, not as a demonstrated outcome for every user or formulation.
It is also unclear whether LipoTrue has published technical dossiers or safety assessments for the three ingredients, when they will be available to formulators, and whether any finished products containing them are planned. The report does not give pricing, supply volumes or details about regulatory status in particular markets. Those points may become clearer through supplier materials and subsequent product development.
Formulator Evaluation and Availability
LipoTrue directed industry visitors to booth V50 at in-cosmetics Asia 2026 to learn about the launches. The next steps for potential customers are likely to involve obtaining technical information and evaluating the actives in prototype formulas, including checks on compatibility, stability, safety and performance. The source report does not announce a later release date or a specific commercial availability schedule.
Further information from LipoTrue, including study methods and data supporting the stated benefits, would help formulators judge how the ingredients perform and what claims may be appropriate for finished products. Any consumer impact will depend on whether brands adopt the actives and how they are used in marketed formulations.
Key Questions
Which ingredients did LipoTrue introduce?
LipoTrue introduced Glintarine™, Red Aternaliss™ and Kalizyme™ at in-cosmetics Asia 2026.
What is each ingredient intended to do?
LipoTrue positions Glintarine for radiance and the appearance of uneven pigmentation, Red Aternaliss for aging-related skin care, and Kalizyme for exfoliation and epidermal renewal. These are the company’s intended cosmetic uses.
Did the announcement include evidence of the ingredients’ effects?
The report summarizes the company’s claims but does not provide study methods, sample sizes or detailed efficacy results. More supporting data would be needed to evaluate the stated effects.
Are the ingredients already in consumer products?
The source report describes ingredient launches for cosmetic formulators; it does not identify finished products containing them or give a consumer-market release date.
Where were the launches presented?
LipoTrue presented the ingredients at in-cosmetics Asia 2026 and said visitors could find them at its booth, V50.
Source: cosmeticsbusiness.com
